Sanofi SA vs TORM plc — how do they compare? Sanofi SA trades at $43.7 (market cap $104.30B), while TORM plc trades at $28.33 (market cap $2.93B). The key difference: Sanofi SA is far larger — about 35.6× TORM plc's market cap, and TORM plc pays the higher dividend (9.77%). Which is the better fit depends on your goals.
| SNY | TRMD | |
|---|---|---|
Market Cap | $104.30B | $2.93B |
Sector | Health | Technology |
52-Week High | $52.34 | $34.87 |
52-Week Low | $41.33 | $18.77 |
Enterprise Value | $124.19B | $3.82B |
Dividend Yield | 5.55% | 9.77% |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →